ShareValue scores for LEOW.XETRA: Valuation 63, Quality 50, Growth 50, Health 54.
LEOW.XETRAXETRA
Leo International Precision Health AG
€0.25
(+12.73%)
Updated
LEOW.XETRAXETRA
Leo International Precision Health AG
Updated
Pulse
Pulse
Fundamental Rating
Value Trap Risk
If P/E met sector median
Rating
Trap Risk
P/E to median
vs Frankfurt-listed Healthcare stocks
Company Details
Leo International Precision Health AG engages in the healthcare technology business in Germany. The company is based in Garching bei München, Germany.
Score Analysis
AI Investment Thesis
Leo International Precision Health AG is fairly valued: its P/B of 0.21 is lower than 96% of Frankfurt-listed healthcare peers, though P/E and EV/EBITDA are not available.
The 0.21 P/B is the decision-relevant fundamental, reflecting a holding company whose value rests on six December 2025 equity contributions rather than demonstrated earnings.
On 13 October 2026 the company executed a 184-for-1 bonus share issue, converting €105.98 million of capital reserves into share capital with no new funds raised.